2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Horizon Two: HR NDMM (MMRC-100)High Risk Newly Diagnosed Multiple MyelomaRecruitingPhase 22026-10-02NCT07053436
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLCALK-Positive Lung Cancer; ALK-positive NSCLC; ALK-positive Non-small Cell Lung CancerRecruitingPhase 1 / Phase 22026-09-03NCT07491497